BIRC5 and neoplasm: The tumor expression levels of VHL, the endothelial marker CD31, PDGFRα, VEGF and the inhibitor of apoptosis survivin (SVV) are supposed to be important markers for prognosis and outcome of patients with advanced RCC [15], [16], [17], [18], [19].